We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Partners to Offer Advanced Microscopy and Data Processing Solutions

By LabMedica International staff writers
Posted on 02 May 2011
Two German companies have signed a co-marketing agreement linking their advanced microscopy and software products.

Leica Microsystems GmbH (Wetzlar, Germany) is a leading global manufacturer of optical microscopes, equipment for the preparation of microscopic specimens, and related products. More...
The company manufactures products for applications requiring microscopic imaging, measurement, and analysis. It also offers system solutions in the areas of life science including biotechnology and medicine, as well as the science of raw materials and industrial quality assurance.

The partner company, Definiens (Munich, Germany), is a leading health image intelligence company that develops software solutions for biomedical image analysis, data mining, and clinical decision support. The company's software analyzes images from cell-based assays, whole tissue slides, and full body scans and allows users to correlate this information with data derived from other sources, supporting better decisions in research, diagnostics, and therapy.

Together the two companies will cooperatively market their complementary products and host joint workshops and educational events.

"Definiens and Leica Microsystems share a commitment to developing powerful imaging solutions that help researchers understand biological pathways faster and more accurately," said Thomas P. Heydler, CEO of Definiens. "This partnership will provide Leica customers with access to Definiens' advanced image analysis software, enabling high-content screening that directly aids drug discovery efforts around the world."

"Together with Definiens, we look forward to the opportunity to make highly developed and future-proof high content screening solutions widely available for academic research as well. The combination of high-sensitivity confocal technology, miniaturized sample handling, and reproducible evaluation with optimized data management is a sine qua non among drug discovery strategies and the analysis of their physiological relevance," said Dr. Stefan Traeger, managing director of the life science division of Leica Microsystems.

Related Links:
Leica Microsystems GmbH
Definiens





Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
New
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.